1)reteplase组织型纤维蛋白溶解酶原激活剂缺失突变体
1.The thrombolytic effect of reteplase in treating rabbit retinal vein occlusion组织型纤维蛋白溶解酶原激活剂缺失突变体治疗兔视网膜静脉阻塞的疗效
英文短句/例句
1.The thrombolytic effect of reteplase in treating rabbit retinal vein occlusion组织型纤维蛋白溶解酶原激活剂缺失突变体治疗兔视网膜静脉阻塞的疗效
2.Intravenous Thrombolysis by Tissue-type Plasminogen Activator Deletion Mutant in a Rabbit Model of Retinal Artery Occlusion两种组织型纤溶酶原激活剂缺失突变体（r-PA）治疗实验性兔视网膜动脉阻塞
3.Construction of Tissue-type Plasminogen Activator Variants and Their Expression in Prokaryotic and Eukaryotic Cells;组织型纤溶酶原激活剂（t-PA）突变体的构建及其表达研究
4.Role of Tissue-Type Plasminogen Activator in Neonatal Rat with Hypoxia-Ischemia Brain Damage组织纤维蛋白溶酶原激活剂在新生大鼠缺氧缺血性脑损伤中的作用
5.Experimental Study on Posterior Vitreous Detachment Induced by Tissue Plasminogen Activator Combined with Hyaluronidase in Rabbits;组织纤维蛋白溶酶原激活剂联合透明质酸酶致玻璃体后脱离的动物实验研究
6.Construction of Tissue Plasminogen Activator-annexin A5 Fusion Gene组织型纤溶酶原激活剂—膜联蛋白A5融合基因的构建
7.Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
8.Establishment of Transgenic Goats for Human Tissue-type Plasminogen Activator with Sperm Mediated Gene Transfer Method;利用精子载体方法研制人组织型纤溶酶原激活剂突变体转基因羊乳腺生物反应器
9.Construction of Bacterial Artificial Chromosome Vectors Containing Human Tissue-type Plasminogen Activator Mutant Gene Specially Expressed in Mammary Gland with Red Recombination System;利用Red系统构建人组织型纤溶酶原激活剂突变体BAC乳腺特异表达载体
10.Construction of Mammary Gland-specific Vector for a Variant of t-PA and Its Expression in Cells;组织型纤溶酶原激活剂（t-PA）突变体乳腺特异性表达载体的构建及其细胞表达研究
11.Expressions of Survivin and uPA in human cerebral gliomas脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达
12.Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
13.DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS慢性扁桃体炎组织中的纤溶酶原激活剂测定
14.Construction of Eukaryotic Expessing Vector of Tissue Plasminogen Activator (t-PA);组织型纤溶酶原激活剂（t-PA）真核表达载体的构建
15.Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理
16.Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价
17.Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效
18.Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例
相关短句/例句
tissue-type plasminogen activator deletion mutant组织型纤溶酶原激活剂缺失突变体
1.To compare the efficiency and safety of intravenous thrombolysis by two kinds of tissue-type plasminogen activator deletion mutants in a rabbit model of retinal artery occlusion established by photochemical method.在兔视网膜动脉阻塞模型上研究两种不同的组织型纤溶酶原激活剂缺失突变体(reteplase,r-PA)的溶栓效果,动态观察视网膜动脉阻塞改变情况、检测血液凝血和纤溶指标以及有无出血并发症等,对比评价两种药物的有效性、安全性。
3)tissue plasminogen activator组织型纤维蛋白溶解酶原激活剂
4)Reteplase重组人组织型纤溶酶原激活剂缺失变体
1.Thrombolysis Effects of Recombinant Human Tissue Type Plasminogen Activator(Reteplase) on Coronary Artery Thrombosis in Dogs;重组人组织型纤溶酶原激活剂缺失变体对犬冠状动脉血栓的溶栓作用
2.Thrombolyti c effect and influence of reteplase on platelet aggregation and the concentration of free calcium in cytoplasma;重组人组织型纤溶酶原激活剂缺失变体的溶栓作用及对血小板聚集和胞浆游离钙离子浓度的影响
3.Effects of reteplase on fibrinolytic and coagulation systems in rabbits;重组人组织型纤溶酶原激活剂缺失变体对家兔纤溶和凝血系统活性的影响
5)human recombinant K_2tPA重组人组织型纤溶酶原激活剂缺失变体(K2tPA)
6)recombinant tissue plasminogen activater(rt-PA)重组组织型纤维蛋白溶酶原激活剂
延伸阅读
组织分子式：CAS号：性质：通常由结构和功能相似的细胞和细胞间物质组成的、具有一定结构的聚集体。
